The DOI matches its Crossref record; 345 of the 347 references it cites were found in a registry or an index.
Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications
Open accessAbstract
Coenzyme Q10 (CoQ10) is an antioxidant, a membrane stabilizer, and a vital cofactor in the mitochondrial electron transport chain, enabling the generation of adenosine triphosphate. It additionally regulates gene expression and apoptosis; is an essential cofactor of uncoupling proteins; and has anti-inflammatory, redox modulatory, and neuroprotective effects. This paper reviews the known physiological role of CoQ10 in cellular metabolism, cell death, differentiation and gene regulation, and examines the potential repercussions of CoQ10 depletion including its role in illnesses such as Parkinson's disease, depression, myalgic encephalomyelitis/chronic fatigue syndrome, and fibromyalgia. CoQ10 depletion may play a role in the pathophysiology of these disorders by modulating cellular processes including hydrogen peroxide formation, gene regulation, cytoprotection, bioenegetic performance, and regulation of cellular metabolism. CoQ10 treatment improves quality of life in patients with Parkinson's disease and may play a role in delaying the progression of that disorder. Administration of CoQ10 has antidepressive effects. CoQ10 treatment significantly reduces fatigue and improves ergonomic performance during exercise and thus may have potential in alleviating the exercise intolerance and exhaustion displayed by people with myalgic encepholamyletis/chronic fatigue syndrome. Administration of CoQ10 improves hyperalgesia and quality of life in patients with fibromyalgia. The evidence base for the effectiveness of treatment with CoQ10 may be explained via its ability to ameliorate oxidative stress and protect mitochondria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CoQ10 has been implicated in the pathophysiology of neuro-immune diseases, including MDD [177].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [177]
In the citing paper
“For example, decreased peripheral levels of CoQ10 have been reported in patients with MDD relative to those measured for controls [177].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [177]
In the citing paper
“As an antioxidant, CoQ10 protects cells from the damaging effects of reactive oxygen species and reactive nitrogen species [177].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Coenzyme Q10 for Parkinson's disease
Liu, J., Wang, L., Zhan, S.-Y., & Xia, Y. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008150.pub3 · Cited by 32
RetractedAutophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Boveris, A., & Chance, B. (1973) · Biochemical Journal · doi:10.1042/bj1340707 · Cited by 2,626
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
(2012) · The Scientific World JOURNAL · doi:10.1100/tswj · Cited by 2,600
Research works printed but not linked: 3
- Jelin JM, Gregory PJ et al (2009) Natural medicines comprehensive database/compiled by the editors of Pharmacist’s Letter, Prescriber’s Letter, 11th edn. Therapeutic Research Faculty, Stockton, CA, pp 452–457
- Nathan N, Van Konynenburg RA (2009) Treatment study of methylation cycle support in patients with chronic fatigue syndrome and fibromyalgia. 9th International IACFS/ME Conference, Reno, Nevada
- Moreno-Fernández AM, Cordero MD, Garrido-Maraver J, Alcocer-Gómez E, Casas-Barquero N, Carmona-López MI, Sánchez-Alcázar JA, de Miguel M (2012) Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients. J Psychiatr Res 46:341–345 · DOI · Paper page
Cited by
Sorted by citations
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Self-citationde Melo, Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Gałecki, P., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 194
Self-citationScaini, G., Rezin, G. T., Carvalho, A. F., STRECK, E. L., Berk, M., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.040 · Cited by 187
Self-citationMorris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Self-citationMorris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 155
Self-citationMitochondrial dysfunction: A fatal blow in depression
Song, Y., Cao, H., Zuo, C., Gu, Z., Huang, Y., Miao, J., Fu, Y., Guo, Y., Jiang, Y., & Wang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115652 · Cited by 141
Salehpour, F., Farajdokht, F., Cassano, P., Sadigh‐Eteghad, S., Erfani, M., Hamblin, M. R., Salimi, M. M., Karimi, P., Rasta, S. H., & Mahmoudi, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.010 · Cited by 138
Wood, E., Hall, K., & Tate, W. P. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.11.002 · Cited by 132
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 119
Self-citationThe Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 115
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
Morris, G., Bortolasci, C. C., Puri, B. K., OLIVE, L. S., Marx, W., O'Neil, A. E., Athan, E., Carvalho, A. F., Maes, M. H. J., Walder, K. R., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118166 · Cited by 107
Self-citationFerroptosis in Acute Central Nervous System Injuries: The Future Direction?
Shen, L., Lin, D., Li, X., Wu, H., Lenahan, C., Pan, Y., Xu, W., Chen, Y., Shao, A., & Zhang, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00594 · Cited by 102
Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 95
Self-citationSlyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Self-citationEndothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 88
Self-citationSharma, R., Rahi, S., & Mehan, S. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.10.019 · Cited by 80
Morris, G., Puri, B. K., Walder, K. R., Berk, M., Stubbs, B., Maes, M. H. J., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1028-6 · Cited by 80
Self-citationAlmulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 79
Self-citationIncreasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Morris, G., Walker, A. J., Walder, K. R., Berk, M., Marx, W., Carvalho, A. F., Maes, M. H. J., & Puri, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02212-w · Cited by 74
Self-citationBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Rosenblat, J. D., McIntyre, R. S., Alves, G. S., Fountoulakis, K. Ν., & Carvalho, A. F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630175044 · Cited by 72
Xie, T., Wang, C., Jin, Y., Meng, Q., Liu, Q., Wu, J., & Sun, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01034 · Cited by 69
Hoepner, C. T., McIntyre, R. S., & Papakostas, G. I. (2021) · Nutrients · doi:10.3390/nu13030767 · Cited by 76
Mohan, S., Alhazmi, H. A., Hassani, R., Khuwaja, G., Maheshkumar, V. P., Aldahish, A. A., & Chidambaram, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24786 · Cited by 70
Morris, G., Walder, K. R., Puri, B. K., Berk, M., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9392-y · Cited by 70
Self-citationVitamin K2 suppresses rotenone-induced microglial activation in vitro
Yu, Y., Li, Y.-P., Gao, F., Hu, Q., Zhang, Y., Chen, D., & Wang, G. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.68 · Cited by 66
Targeting the immune system in the treatment of bipolar disorder
Rosenblat, J. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5175-x · Cited by 64
Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article
Bagheri, S., Haddadi, R., Saki, S., Kourosh‐Arami, M., Rashno, M., Mojaver, A., & Komaki, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1188839 · Cited by 74
Castro‐Marrero, J., Segundo, M. J., Lacasa, M., Martínez-Martínez, A., Sentañes, R. S., & Alegre, J. (2021) · Nutrients · doi:10.3390/nu13082658 · Cited by 63
Abuelezz, S. A., Hendawy, N., & Magdy, Y. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9712-7 · Cited by 61
Redox Characterization of Functioning Skeletal Muscle
Zuo, L., & Pannell, B. K. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00338 · Cited by 60
Farsi, F., Heshmati, J., Keshtkar, A., Irandoost, P., Alamdari, N. M., Akbari, A., Janani, L., Morshedzadeh, N., & Vafa, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104290 · Cited by 58
Mehrpooya, M., Yasrebifar, F., Haghighi, M., Mohammadi, Y., & Jahangard, L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000938 · Cited by 57
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Walder, K. R., Mazza, C., & Berk, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104450 · Cited by 47
Self-citationStatins and Neuroprotection: Basic Pharmacology Needed
Wood, W. G., Mΰller, W. E., & Eckert, G. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8647-3 · Cited by 46
Johansson, P., Dahlström, Ö., Dahlström, U., & Alehagen, U. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0509-9 · Cited by 45
Morris, G., Walder, K. R., Berk, M., Marx, W., Walker, A. J., Maes, M. H. J., & Puri, B. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05590-5 · Cited by 47
Self-citationAndalib, S., Mashhadi-Mousapour, M., Bijani, S., & Hosseini, M.-J. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02761-0 · Cited by 43
Mitochondrial Agents for Bipolar Disorder
Pereira, C. L., Chavarria, V., Vian, J., Ashton, M. M., Berk, M., Marx, W., & Dean, O. M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy018 · Cited by 41
Self-citationInduced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?
Morris, G., Puri, B. K., Carvalho, A. F., Maes, M. H. J., Berk, M., Ruusunen, A. A., & OLIVE, L. S. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa008 · Cited by 42
Self-citationZhao, D., Wu, Y., Zhao, H., Zhang, F., Wang, J., Liu, Y., Lin, J., Huang, Y., Pan, W., Qi, J., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.004 · Cited by 38
Zhang, X., Liu, H., Hao, Y., Xu, L., Zhang, T., Liu, Y., Guo, L., Zhu, L., & Pei, Z. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0928-9 · Cited by 35
Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Bortolato, B., Berk, M., Maes, M. H. J., McIntyre, R. S., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144027 · Cited by 34
Self-citationMonro, J. A., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0928-9 · Cited by 35
Karamali, M., & Gholizadeh, M. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1991910 · Cited by 33
Coenzyme Q10 Regulates Serotonin Levels and Depressive Symptoms in Fibromyalgia Patients
Alcocer‐Gómez, E., Sánchez-Alcázar, J. A., & Cordero, M. D. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000097 · Cited by 32
The compensatory antioxidant response system with a focus on neuroprogressive disorders
Morris, G., Puri, B. K., Walker, A. J., Berk, M., Walder, K. R., Bortolasci, C. C., Marx, W., Carvalho, A. F., & Maes, M. H. J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109708 · Cited by 33
Self-citationCoenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia
Maguire, Á., Hargreaves, A., & Gill, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1556481 · Cited by 30
Coenzyme Q homeostasis in aging: Response to non-genetic interventions
López‐Lluch, G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.024 · Cited by 29
Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?
Ben‐Shachar, D., & Ene, H. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.007 · Cited by 27
Vieira, W. F., Gersten, M. B., Caldieraro, M. A., & Cassano, P. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000363 · Cited by 25
Targeting Mitochondrial Dysfunction for Bipolar Disorder
Kuperberg, M., Greenebaum, S. L. A., & Nierenberg, A. A. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_152 · Cited by 25
Abuelezz, S. A., Hendawy, N., & Magdy, Y. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.018 · Cited by 23
Campenhout, J. V., Buntinx, Y., Xiong, H.-Y., Wyns, A., Polli, A., Nijs, J., Aerts, J. L., Laeremans, T., & Hendrix, J. (2025) · Biomolecules · doi:10.3390/biom15030357 · Cited by 22
Farsi, F., Ebrahimi‐Daryani, N., Golab, F., Akbari, A., Janani, L., Karimi, M. Y., Irandoost, P., Alamdari, N. M., Agah, S., & Vafa, M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02514-2 · Cited by 18
RetractedCoenzyme Q10 Levels Associated With Cognitive Functioning and Executive Function in Older Adults
Fernández-Portero, C., Amián, J. G., de la Bella, R., López‐Lluch, G., & Alarcón, D. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac152 · Cited by 15
Zahrooni, N., Hosseini, S. A., Ahmadzadeh, A., Angali, K. A., & Assarehzadegan, M. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s234930 · Cited by 14
Nattagh‐Eshtivani, E., Dahri, M., Hashemilar, M., & Tarighat‐Esfanjani, A. (2018) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2018.06.009 · Cited by 14
Watanabe, K., Nozaki, S., Goto, M., Kaneko, K., Hayashinaka, E., Irie, S., Nishiyama, A., Kasai, K., Fujii, K., Wada, Y., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.073 · Cited by 13
Farsi, F., Ebrahimi‐Daryani, N., Barati, M., Janani, L., Karimi, M. Y., Akbari, A., Irandoost, P., Alamdari, N. M., Agah, S., & Vafa, M. (2021) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.35.3 · Cited by 12
Morris, G., Walder, K. R., Berk, M., Carvalho, A. F., Marx, W., Bortolasci, C. C., Yung, A. R., Puri, B. K., & Maes, M. H. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110481 · Cited by 13
Self-citationMaes, M. H. J., & Leunis, J. (2014) · PubMed · Cited by 12
Self-citationDuong, A., Che, Y., Ceylan, D., Pinguelo, A., Andreazza, A. C., Young, L. T., & Berk, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.015 · Cited by 12
Self-citationImpact of coenzyme Q10 on inflammatory biomarkers and its role in future therapeutic strategies
Abiri, B., & Vafa, M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.04.005 · Cited by 14
The Effects of Long-Term Ubiquinol Intake on Improving the Quality of Life of Community Residents
Kinoshita, T., Maruyama, K., & Tanigawa, T. (2016) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v6i1.225 · Cited by 12
Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches
Marano, G., Lisci, F. M., Boggio, G., Marzo, E. M., Abate, F., Sfratta, G., Traversi, G., Mazza, O., Pola, R., Sani, G., et al. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5030042 · Cited by 8
Nyariki, J. N., Kimani, N. M., Kibet, P. S., Kinuthia, G. K., & Isaac, A. O. (2023) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2023.111579 · Cited by 8
Plotnikoff, G. A., & Barber, M. S. (2016) · The Permanente Journal · doi:10.7812/tpp/15-242 · Cited by 8
Novel Therapeutic Targets for Major Depressive Disorder
Lazar, M. A., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00034-2 · Cited by 9
Hosseini, S. A., Zahrooni, N., Ahmadzadeh, A., Angali, K. A., & Assarehzadegan, M. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s241431 · Cited by 8
Sharma, R., Tiwari, A., Rahi, S., & Mehan, S. (2020) · Current Psychopharmacologye · doi:10.2174/1389203721999200820165117 · Cited by 6
Farsi, F., Heshmati, J., Janani, L., Irandoost, P., Alamdari, N. M., Keshtkar, A., Akbari, A., & Vafa, M. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016841 · Cited by 6
Nasehi, L., Morassaei, B., Ghaffari, M., Sharafi, A., Dehpour, A. R., & Hosseini, M.-J. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0098 · Cited by 5
Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · medRxiv · doi:10.1101/2023.03.20.23287483 · Cited by 5
Self-citationTherapeutic implication of coenzyme Q10 during statin therapy: pros and cons
Cons, Hosseini, M.-J., & Mohammadi‐Bardbori, A. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1111/tips.v1i3.29 · Cited by 4
Maes, M. H. J., Kubera, M., Stoyanova, K., & Leunis, J. (2021) · Preprints.org · doi:10.20944/preprints202101.0623.v1 · Cited by 4
Self-citationAlshali, R. A. (2024) · International Journal of Pharmacology · doi:10.3923/ijp.2024.1163.1180 · Cited by 3
Sriretnakumar, V., Harripaul, R., Kennedy, J. L., & So, J. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63609 · Cited by 4
Oxidative Stress Reduction (Prong-3)
DePace, N. L., & Colombo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17016-5_5 · Cited by 3
Akwan, R., Elsharkawy, M. M., Zrineh, A., Amleh, A., Douden, B., Alhouseini, M., Alsaeed, L., & Eldesouki, M. H. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03904-9 · Cited by 2
Mao, X., Li, X., Wang, L., Song, K., Zhang, C., Chen, K.-Q., & Lu, K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148436 · Cited by 2
Dizaji, R., Sharafi, A., Pourahmad, J., Vatanpour, S., Dinmohammadi, H., Vatanpour, H., & Hosseini, M. (2022) · Bioimpacts · doi:10.34172/bi.2022.23422 · Cited by 2
Şakar, A. E., YALÇIN, O. K., Mazi, A., & Yildiz, C. (2025) · Biopreservation and Biobanking · doi:10.1089/bio.2023.0084 · Cited by 1
Kirbaeva, N. V., Шаранова, Н. Э., Zhminchenko, V. M., & Васильев, А. В. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4156-0 · Cited by 1
Vallings, R. (2019) · Journal of Primary Health Care · doi:10.1071/hcv11n4_ed2 · Cited by 1
Coenzyme Q10: Current Overview
Erdoğan, K., Macit, M. S., Şanlıer, N. T., & Üstün, Y. E. (2022) · Türk Kadın Sağlığı ve Neonatoloji Dergisi · doi:10.46969/ezh.1002286 · Cited by 2
Complementary and Integrative Therapies for Older Age Bipolar Disorder
Poscablo-Stein, M. C., & Hermida, A. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_10
Novel therapeutic drug targets for bipolar disorder
Rosenblat, J. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00037-5
標準予防策の徹底に向けた感染制御スタッフの育成 (特集 職員への対策からはじまる感染予防)
大澤, 栄. (2013) · 看護実践の科学
Alshali, R. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4551946/v1
Charnolosome nanotheranostics in neuropsychiatric diseases
Sharma, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21752-4.00040-7
Ke, Y.-X., Mao, X., Li, X., Wang, L., Song, K., Zhang, C.-X., Huang, B., & Lu, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642039
de Souza, C. S. H., Vieira, F. V., Maciel, T. D. S., Rojas, V. C. T., Novais, C. O., Filho, S. N. S., Giusti‐Paiva, A., dos Anjos‐Garcia, T., Kalil, B., & Vilela, F. C. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100268
Ngoh, S. H., & Gudi, A. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07905-5
Alabrahim, O. A. A., & Allam, N. K. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00413-9
Şakar, A. E., Yıldız, C., ÇETİN, N. C., Şengül, S. A., Kazak, F., Kutlu, T., Sayan, M., & Karabulut, D. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02235-z
Metadata
- Authors
- Morris, G., Anderson, G., Berk, M., & Maes, M.
- Affiliations
- Deakin University (AU)
- Corresponding author
- Maes, Michael
- Venue
- Molecular Neurobiology
- Published
- 2013-06-13
- Volume
- 48
- Issue
- 3
- Pages
- 883-903
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2058368383
- Cited by
- 96
- References
- 347
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 10 · 2020: 11 · 2019: 13 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 3 · 2013: 2
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Servier
- H. Lundbeck A/S
- Cilag
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- coenzyme Q10, Parkinson's disease, depression, chronic fatigue syndrome, fibromyalgia, oxidative stress, mitochondrial dysfunction, neuroprotection, antioxidants, uncoupling proteins, hydrogen peroxide, exercise intolerance, hyperalgesia, mitochondrial electron transport chain, apoptosis, gene expression regulation
- MeSH terms
- Mental Disorders, Humans, Ubiquinone, Signal Transduction, Nitrosation, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review